Northwestern Mutual Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-440
Closed 3527
2022
Q3
$0 Hold
440
﹤0.01% 3513
2022
Q2
$1K Sell
440
-2,000
-82% -$2.95K ﹤0.01% 3126
2022
Q1
$5K Buy
2,440
+1,939
+387% +$3.81K ﹤0.01% 2769
2021
Q4
$1K Buy
501
+451
+902% +$1.67K ﹤0.01% 3094
2021
Q3
$0 Buy
+50
New +$241 ﹤0.01% 3311
2019
Q4
Sell
-150
Closed -$1K 2687
2019
Q3
$1K Buy
+150
New +$1.21K ﹤0.01% 2418

Other funds holding CLVS

Northwestern Mutual Wealth Management's CLVS Position: Q4 2022 in Review

Northwestern Mutual Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 440 shares.

Northwestern Mutual Wealth Management first reported a position in CLVS in Q3 2019 and held it in 6 quarters. The position peaked at $5K in Q1 2022. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Northwestern Mutual Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 440 Clovis Oncology, Inc. shares in Q4 2022.
  • Northwestern Mutual Wealth Management first reported a position in Clovis Oncology, Inc. in Q3 2019 and held it in 6 quarters.
  • Northwestern Mutual Wealth Management's Clovis Oncology, Inc. position peaked at $5K in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2022, filed 21 Feb 2023.